Author

Zhuting Fang

Fujian Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chengye LiuiD· 2 shared Hongwu Yu· 2 shared Peng LiniD· 2 shared Shenglin HuangiD· 2 shared Yifan Wen· 2 shared Feifei Zhang· 1 shared Jingjing ZhaoiD· 1 shared Linhui Liang· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chengye LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Decoding Neoantigen-encoding Tumor-Specific Transcripts Unveils a Shared Target Reservoir for Immunotherapy in Hepatocellular Carcinoma

Peng Lin, Yifan Wen, Jingjing Zhao, Feifei Zhang, Yaoming Su, Hongwu Yu, Yu Hx, Qiaojuan Li, Chengye Liu, Zhixiang Hu, Yan Li, Zhuting Fang, Linhui Liang, Shenglin Huang

This paper identifies neoantigen-encoding tumor-specific transcripts (neoTSTs) in hepatocellular carcinoma, showing they are more abundant and immunogenic than mutation-derived neoantigens, and demonstrate therapeutic potential in preclinical models.

Journal for ImmunoTherapy of Cancer · Jul 1, 2026Peer-reviewedCancer Biology

Engineering Linear Cap-independent mRNA Vaccines with Intrinsic Adjuvanticity for Potent Cancer Immunotherapy

Hongwu Yu, Yu Yang, Peng Lin, Chengye Liu, Yifan Wen, Zhuting Fang, Zhixiang Hu, Shenglin Huang

This paper develops a cap-independent mRNA vaccine platform that enhances antitumor immunity through intrinsic adjuvanticity and improved in vivo expression.

bioRxiv · Oct 27, 2025 · PreprintBioengineering